Try it
Pharmacology · Chemotherapy: methotrexate interaction mechanism
Sample itemA boy with osteosarcoma receiving high-dose methotrexate is given ibuprofen and piperacillin for fever. He develops severe mucositis and pancytopenia with a persistently high methotrexate level. What best explains the toxicity?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Competition for tubular secretion delays methotrexate clearance
Methotrexate is eliminated mainly by renal excretion, including active tubular secretion. Weak organic acids such as NSAIDs, penicillins and probenecid compete for this transport, and NSAIDs can also lower renal blood flow, so the level stays high and toxicity follows.
Option by option
A. Induction of dihydrofolate reductase in marrow cells
Induction of dihydrofolate reductase would reduce rather than increase methotrexate toxicity.
B. Reduced intestinal absorption of folinic acid
Folinic acid is given parenterally for rescue, and its absorption is not the issue.
C. Inhibition of hepatic CYP3A4 metabolism of methotrexate
Methotrexate is not significantly metabolised by CYP3A4 in the liver.
D. Competition for tubular secretion delays methotrexate clearance (correct)
Correct. NSAIDs and penicillins compete with methotrexate for tubular secretion.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?